These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11919427)

  • 1. Mastocytosis: mediator-related signs and symptoms.
    Castells M; Austen KF
    Int Arch Allergy Immunol; 2002 Feb; 127(2):147-52. PubMed ID: 11919427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current options in the treatment of mast cell mediator-related symptoms in mastocytosis.
    Escribano L; Akin C; Castells M; Schwartz LB
    Inflamm Allergy Drug Targets; 2006 Jan; 5(1):61-77. PubMed ID: 16613565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of mastocytosis.
    Tharp MD
    Am J Med Sci; 1985 Mar; 289(3):119-32. PubMed ID: 2579553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastocytosis: classification, diagnosis, and clinical presentation.
    Castells MC
    Allergy Asthma Proc; 2004; 25(1):33-6. PubMed ID: 15055560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular symptoms in patients with systemic mast cell activation disease.
    Kolck UW; Haenisch B; Molderings GJ
    Transl Res; 2016 Aug; 174():23-32.e1. PubMed ID: 26775802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic mastocytosis: significance of contemporary methods of imaging in diagnosis of this disease].
    Błaszczyk B; Brzezińska-Błaszczyk E
    Przegl Lek; 1994; 51(6):249-54. PubMed ID: 7938660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.
    Rastogi V; Singh D; Mazza JJ; Parajuli D; Yale SH
    Clin Med Res; 2018 Jun; 16(1-2):16-28. PubMed ID: 29650525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis presenting as a skeletal disorder.
    Delsignore JL; Dvoretsky PM; Hicks DG; O'Keefe RJ; Rosier RN
    Iowa Orthop J; 1996; 16():126-34. PubMed ID: 9129284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal manifestations of systemic mastocytosis.
    Lee JK; Whittaker SJ; Enns RA; Zetler P
    World J Gastroenterol; 2008 Dec; 14(45):7005-8. PubMed ID: 19058339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.
    Gruson B; Lortholary O; Canioni D; Chandesris O; Lanternier F; Bruneau J; Grosbois B; Livideanu C; Larroche C; Durieu I; Barete S; Sevestre H; Diouf M; Chaby G; Marolleau JP; Dubreuil P; Hermine O; Damaj G
    Br J Haematol; 2013 May; 161(3):434-42. PubMed ID: 23432617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches to the diagnosis and treatment of systemic mastocytosis.
    Bains SN; Hsieh FH
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic mast cell disease: a review of the literature with special focus on the gastrointestinal manifestations.
    Debeuckelaere S; Schoors DF; Devis G
    Acta Clin Belg; 1991; 46(4):226-32. PubMed ID: 1683083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New views on systemic mastocytosis].
    Pluta A; Gutkowski K
    Pol Merkur Lekarski; 2003 Feb; 14(80):159-62. PubMed ID: 12728681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
    Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F
    Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mastocytosis: current concepts in diagnosis and treatment.
    Escribano L; Akin C; Castells M; Orfao A; Metcalfe DD
    Ann Hematol; 2002 Dec; 81(12):677-90. PubMed ID: 12483363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic mastocytosis: current concepts and treatment advances.
    Tefferi A; Pardanani A
    Curr Hematol Rep; 2004 May; 3(3):197-202. PubMed ID: 15087068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic symptoms and diagnosis in adults with mast cell disease.
    Smith JH; Butterfield JH; Pardanani A; DeLuca GC; Cutrer FM
    Clin Neurol Neurosurg; 2011 Sep; 113(7):570-4. PubMed ID: 21664760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mast cell and mast cell disease.
    Longley J; Duffy TP; Kohn S
    J Am Acad Dermatol; 1995 Apr; 32(4):545-61; quiz 562-4. PubMed ID: 7896943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.